Specialties

Dr. George Bakris explains the new ADA blood pressure guidelines in a talk with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the links between cardiovascular and kidney diseases.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the increase of people on dialysis due to increase in kidney disease but decrease in cardiovascular mortality.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the possible kidney benefits for those using SGLT-2s.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about what he is looking forward to in the results of some promising diabetes trials.

Combination ANRI sacubitril/valsartan (EntrestoR) showed significant reduction in risk for cardiovascular death and hospitalization for worsening heart failure.

Study prompts more concerns for future seniors with diabetes.

Study authors sought to characterize the tolerance test, and HbA1c—in a population of patients with coronary artery disease (CAD).

Study aims to distinguish different antidiabetic drugs and their effect on osteoporosis in people with diabetes.

Older adults taking five or more drugs are likely to exhibit negative side effects.